Achieving >70% AMI-CS Survival: Insight From National Cardiogenic Shock Initiative

Presented by William O'Neill, MD

William O’Neill, MD, discusses insights from the National Cardiogenic Shock Initiative (NCSI) which is driving improvement in outcomes in patients with AMI cardiogenic shock. Dr. O’Neill describes the algorithm and explains how cardiac power output (CPO) and pulmonary artery pulsatility index (PAPI) are used to drive care for patients after angioplasty. He then discusses the following key learnings from NCSI:

  • Identify and support cardiogenic shock early
  • Aggressively down-titration inotropes
  • Identify inadequate LV support and escalate – “If CPO <0.8, you must escalate!
  • Identify RV dysfunction early and support
  • Systematically use right heart catheter (RHC)/pulmonary artery catheter (PAC) to guide therapy

Dr. O’Neill is medical director of the Center for Structural Heart Disease, Henry Ford System, Detroit, Michigan.

This video is part of a series: Achieving >70% AMI-CS Survival: Best Practices From Around the World

View our full TCT Connect coverage on ProtectedPCI.com.

IMP-1662
IMP-1759

Subscribe or join the conversation by following us on Twitter: @ProtectedPCI


To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use of the devices, please visit: abiomed.com/important-safety-information

Subscribe to the Digital Community

Receive weekly updates including case review videos, tips and tricks, specialists opinions, and resources and downloads regarding Protected PCI and Cardiogenic Shock.

Subscribe to the Digital Community

Receive weekly updates including case review videos, tips and tricks, specialists opinions, and resources and downloads regarding Protected PCI and Cardiogenic Shock.